Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Injectable Implant Urinary Incontinence Device Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Injectable Implant Urinary Incontinence Device Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Medical Devices & Consumables

Published Date: 2025-11-02

Pages: 118 Pages

Report ld: 5344749

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Injectable Implant Urinary Incontinence Device Market Size(US$)

CAGR 2025-2031

5.9%

Market Size,2031

USD 185

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 131 million

Market Forecast in 2031(Value)

US$ 185 million

CAGR

5.9%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Injectable Implant Urinary Incontinence Device market is projected to grow from US$ 124 million in 2024 to US$ 185 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Injectable Implant Urinary Incontinence Device market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

Boston Scientific
Laborie Medical
Urogyn B.V.

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Stress Incontinence
Urge Incontinence
Overflow Incontinence
Functional Incontinence
Others

Segment by Application

Hospitals and Clinics
Ambulatory Surgery Centres
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the Injectable Implant Urinary Incontinence Device study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.

Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.

Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to Injectable Implant Urinary Incontinence Device: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Injectable Implant Urinary Incontinence Device Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Stress Incontinence

1.2.3 Urge Incontinence

1.2.4 Overflow Incontinence

1.2.5 Functional Incontinence

1.2.6 Others

1.3 Market Segmentation by Application

1.3.1 Global Injectable Implant Urinary Incontinence Device Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospitals and Clinics

1.3.3 Ambulatory Surgery Centres

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Injectable Implant Urinary Incontinence Device Revenue Estimates and Forecasts 2020-2031

2.2 Global Injectable Implant Urinary Incontinence Device Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Injectable Implant Urinary Incontinence Device Sales Estimates and Forecasts 2020-2031

2.4 Global Injectable Implant Urinary Incontinence Device Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Injectable Implant Urinary Incontinence Device Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Injectable Implant Urinary Incontinence Device Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Stress Incontinence Market Size by Manufacturers

3.5.2 Urge Incontinence Market Size by Manufacturers

3.5.3 Overflow Incontinence Market Size by Manufacturers

3.5.4 Functional Incontinence Market Size by Manufacturers

3.5.5 Others Market Size by Manufacturers

3.6 Global Injectable Implant Urinary Incontinence Device Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Injectable Implant Urinary Incontinence Device Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Injectable Implant Urinary Incontinence Device Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Injectable Implant Urinary Incontinence Device Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Injectable Implant Urinary Incontinence Device Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Injectable Implant Urinary Incontinence Device Sales and Revenue by Type (2020-2031)

6.4 North America Injectable Implant Urinary Incontinence Device Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Injectable Implant Urinary Incontinence Device Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Injectable Implant Urinary Incontinence Device Sales and Revenue by Type (2020-2031)

7.4 Europe Injectable Implant Urinary Incontinence Device Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Injectable Implant Urinary Incontinence Device Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Injectable Implant Urinary Incontinence Device Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Injectable Implant Urinary Incontinence Device Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Injectable Implant Urinary Incontinence Device Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Injectable Implant Urinary Incontinence Device Sales and Revenue by Type (2020-2031)

9.4 Central and South America Injectable Implant Urinary Incontinence Device Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Injectable Implant Urinary Incontinence Device Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Injectable Implant Urinary Incontinence Device Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Injectable Implant Urinary Incontinence Device Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Injectable Implant Urinary Incontinence Device Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Boston Scientific

11.1.1 Boston Scientific Corporation Information

11.1.2 Boston Scientific Business Overview

11.1.3 Boston Scientific Injectable Implant Urinary Incontinence Device Product Models, Descriptions and Specifications

11.1.4 Boston Scientific Injectable Implant Urinary Incontinence Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Boston Scientific Injectable Implant Urinary Incontinence Device Sales by Product in 2024

11.1.6 Boston Scientific Injectable Implant Urinary Incontinence Device Sales by Application in 2024

11.1.7 Boston Scientific Injectable Implant Urinary Incontinence Device Sales by Geographic Area in 2024

11.1.8 Boston Scientific Injectable Implant Urinary Incontinence Device SWOT Analysis

11.1.9 Boston Scientific Recent Developments

11.2 Laborie Medical

11.2.1 Laborie Medical Corporation Information

11.2.2 Laborie Medical Business Overview

11.2.3 Laborie Medical Injectable Implant Urinary Incontinence Device Product Models, Descriptions and Specifications

11.2.4 Laborie Medical Injectable Implant Urinary Incontinence Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Laborie Medical Injectable Implant Urinary Incontinence Device Sales by Product in 2024

11.2.6 Laborie Medical Injectable Implant Urinary Incontinence Device Sales by Application in 2024

11.2.7 Laborie Medical Injectable Implant Urinary Incontinence Device Sales by Geographic Area in 2024

11.2.8 Laborie Medical Injectable Implant Urinary Incontinence Device SWOT Analysis

11.2.9 Laborie Medical Recent Developments

11.3 Urogyn B.V.

11.3.1 Urogyn B.V. Corporation Information

11.3.2 Urogyn B.V. Business Overview

11.3.3 Urogyn B.V. Injectable Implant Urinary Incontinence Device Product Models, Descriptions and Specifications

11.3.4 Urogyn B.V. Injectable Implant Urinary Incontinence Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Urogyn B.V. Injectable Implant Urinary Incontinence Device Sales by Product in 2024

11.3.6 Urogyn B.V. Injectable Implant Urinary Incontinence Device Sales by Application in 2024

11.3.7 Urogyn B.V. Injectable Implant Urinary Incontinence Device Sales by Geographic Area in 2024

11.3.8 Urogyn B.V. Injectable Implant Urinary Incontinence Device SWOT Analysis

11.3.9 Urogyn B.V. Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Injectable Implant Urinary Incontinence Device Industry Chain

12.2 Injectable Implant Urinary Incontinence Device Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Injectable Implant Urinary Incontinence Device Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Injectable Implant Urinary Incontinence Device Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Injectable Implant Urinary Incontinence Device Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Injectable Implant Urinary Incontinence Device Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Injectable Implant Urinary Incontinence Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Injectable Implant Urinary Incontinence Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Injectable Implant Urinary Incontinence Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Injectable Implant Urinary Incontinence Device Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Injectable Implant Urinary Incontinence Device Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Injectable Implant Urinary Incontinence Device Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Injectable Implant Urinary Incontinence Device Sales by Region (2020-2025) & (K Units)

Table 8. Global Injectable Implant Urinary Incontinence Device Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Injectable Implant Urinary Incontinence Device Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Injectable Implant Urinary Incontinence Device Sales Share by Manufacturers (2020-2025)

Table 12. Global Injectable Implant Urinary Incontinence Device Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Injectable Implant Urinary Incontinence Device Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Injectable Implant Urinary Incontinence Device by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Implant Urinary Incontinence Device as of 2024)

Table 16. Global Injectable Implant Urinary Incontinence Device Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Injectable Implant Urinary Incontinence Device Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Injectable Implant Urinary Incontinence Device Manufacturing Base and Headquarters

Table 19. Global Injectable Implant Urinary Incontinence Device Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Injectable Implant Urinary Incontinence Device Sales by Type (2020-2025) & (K Units)

Table 23. Global Injectable Implant Urinary Incontinence Device Sales by Type (2026-2031) & (K Units)

Table 24. Global Injectable Implant Urinary Incontinence Device Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Injectable Implant Urinary Incontinence Device Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Injectable Implant Urinary Incontinence Device ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Injectable Implant Urinary Incontinence Device Sales by Application (2020-2025) & (K Units)

Table 29. Global Injectable Implant Urinary Incontinence Device Sales by Application (2026-2031) & (K Units)

Table 30. Injectable Implant Urinary Incontinence Device High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Injectable Implant Urinary Incontinence Device Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Injectable Implant Urinary Incontinence Device Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Injectable Implant Urinary Incontinence Device ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Injectable Implant Urinary Incontinence Device Growth Accelerators and Market Barriers

Table 37. North America Injectable Implant Urinary Incontinence Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Injectable Implant Urinary Incontinence Device Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Injectable Implant Urinary Incontinence Device Growth Accelerators and Market Barriers

Table 40. Europe Injectable Implant Urinary Incontinence Device Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Injectable Implant Urinary Incontinence Device Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Injectable Implant Urinary Incontinence Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Injectable Implant Urinary Incontinence Device Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Injectable Implant Urinary Incontinence Device Growth Accelerators and Market Barriers

Table 45. Southeast Asia Injectable Implant Urinary Incontinence Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Injectable Implant Urinary Incontinence Device Investment Opportunities and Key Challenges

Table 47. Central and South America Injectable Implant Urinary Incontinence Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Injectable Implant Urinary Incontinence Device Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Injectable Implant Urinary Incontinence Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Boston Scientific Corporation Information

Table 51. Boston Scientific Description and Major Businesses

Table 52. Boston Scientific Product Models, Descriptions and Specifications

Table 53. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Boston Scientific Sales Value Proportion by Product in 2024

Table 55. Boston Scientific Sales Value Proportion by Application in 2024

Table 56. Boston Scientific Sales Value Proportion by Geographic Area in 2024

Table 57. Boston Scientific Injectable Implant Urinary Incontinence Device SWOT Analysis

Table 58. Boston Scientific Recent Developments

Table 59. Laborie Medical Corporation Information

Table 60. Laborie Medical Description and Major Businesses

Table 61. Laborie Medical Product Models, Descriptions and Specifications

Table 62. Laborie Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Laborie Medical Sales Value Proportion by Product in 2024

Table 64. Laborie Medical Sales Value Proportion by Application in 2024

Table 65. Laborie Medical Sales Value Proportion by Geographic Area in 2024

Table 66. Laborie Medical Injectable Implant Urinary Incontinence Device SWOT Analysis

Table 67. Laborie Medical Recent Developments

Table 68. Urogyn B.V. Corporation Information

Table 69. Urogyn B.V. Description and Major Businesses

Table 70. Urogyn B.V. Product Models, Descriptions and Specifications

Table 71. Urogyn B.V. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Urogyn B.V. Sales Value Proportion by Product in 2024

Table 73. Urogyn B.V. Sales Value Proportion by Application in 2024

Table 74. Urogyn B.V. Sales Value Proportion by Geographic Area in 2024

Table 75. Urogyn B.V. Injectable Implant Urinary Incontinence Device SWOT Analysis

Table 76. Urogyn B.V. Recent Developments

Table 77. Key Raw Materials Distribution

Table 78. Raw Materials Key Suppliers

Table 79. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 80. Milestones in Production Technology Evolution

Table 81. Distributors List

Table 82. Market Trends and Market Evolution

Table 83. Market Drivers and Opportunities

Table 84. Market Challenges, Risks, and Restraints

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

List of Figures

Figure 1. Injectable Implant Urinary Incontinence Device Product Picture

Figure 2. Global Injectable Implant Urinary Incontinence Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Stress Incontinence Product Picture

Figure 4. Urge Incontinence Product Picture

Figure 5. Overflow Incontinence Product Picture

Figure 6. Functional Incontinence Product Picture

Figure 7. Others Product Picture

Figure 8. Global Injectable Implant Urinary Incontinence Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 9. Hospitals and Clinics

Figure 10. Ambulatory Surgery Centres

Figure 11. Others

Figure 12. Injectable Implant Urinary Incontinence Device Report Years Considered

Figure 13. Global Injectable Implant Urinary Incontinence Device Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Injectable Implant Urinary Incontinence Device Revenue (2020-2031) & (US$ Million)

Figure 15. Global Injectable Implant Urinary Incontinence Device Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 16. Global Injectable Implant Urinary Incontinence Device Revenue Market Share by Region (2020-2031)

Figure 17. Global Injectable Implant Urinary Incontinence Device Sales (2020-2031) & (K Units)

Figure 18. Global Injectable Implant Urinary Incontinence Device Sales (CAGR) by Region (2020-2031) (K Units)

Figure 19. Global Injectable Implant Urinary Incontinence Device Sales Market Share by Region (2020-2031)

Figure 20. Top 5 and Top 10 Manufacturers Injectable Implant Urinary Incontinence Device Sales Volume Market Share in 2024

Figure 21. Global Injectable Implant Urinary Incontinence Device Revenue Market Share Ranking (2024)

Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 23. Stress Incontinence Revenue Market Share by Manufacturer in 2024

Figure 24. Urge Incontinence Revenue Market Share by Manufacturer in 2024

Figure 25. Overflow Incontinence Revenue Market Share by Manufacturer in 2024

Figure 26. Functional Incontinence Revenue Market Share by Manufacturer in 2024

Figure 27. Others Revenue Market Share by Manufacturer in 2024

Figure 28. Global Injectable Implant Urinary Incontinence Device Sales Market Share by Type (2020-2031)

Figure 29. Global Injectable Implant Urinary Incontinence Device Revenue Market Share by Type (2020-2031)

Figure 30. Global Injectable Implant Urinary Incontinence Device Sales Market Share by Application (2020-2031)

Figure 31. Global Injectable Implant Urinary Incontinence Device Revenue Market Share by Application (2020-2031)

Figure 32. North America Injectable Implant Urinary Incontinence Device Sales YoY (2020-2031) & (K Units)

Figure 33. North America Injectable Implant Urinary Incontinence Device Revenue YoY (2020-2031) & (US$ Million)

Figure 34. North America Top 5 Manufacturers Injectable Implant Urinary Incontinence Device Sales Revenue (US$ Million) in 2024

Figure 35. North America Injectable Implant Urinary Incontinence Device Sales Volume (K Units) by Type (2020- 2031)

Figure 36. North America Injectable Implant Urinary Incontinence Device Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 37. North America Injectable Implant Urinary Incontinence Device Sales Volume (K Units) by Application (2020-2031)

Figure 38. North America Injectable Implant Urinary Incontinence Device Sales Revenue (US$ Million) by Application (2020-2031)

Figure 39. US Injectable Implant Urinary Incontinence Device Revenue (2020-2031) & (US$ Million)

Figure 40. Canada Injectable Implant Urinary Incontinence Device Revenue (2020-2031) & (US$ Million)

Figure 41. Mexico Injectable Implant Urinary Incontinence Device Revenue (2020-2031) & (US$ Million)

Figure 42. Europe Injectable Implant Urinary Incontinence Device Sales YoY (2020-2031) & (K Units)

Figure 43. Europe Injectable Implant Urinary Incontinence Device Revenue YoY (2020-2031) & (US$ Million)

Figure 44. Europe Top 5 Manufacturers Injectable Implant Urinary Incontinence Device Sales Revenue (US$ Million) in 2024

Figure 45. Europe Injectable Implant Urinary Incontinence Device Sales Volume (K Units) by Type (2020-2031)

Figure 46. Europe Injectable Implant Urinary Incontinence Device Sales Revenue (US$ Million) by Type (2020-2031)

Figure 47. Europe Injectable Implant Urinary Incontinence Device Sales Volume (K Units) by Application (2020-2031)

Figure 48. Europe Injectable Implant Urinary Incontinence Device Sales Revenue (US$ Million) by Application (2020-2031)

Figure 49. Germany Injectable Implant Urinary Incontinence Device Revenue (2020-2031) & (US$ Million)

Figure 50. France Injectable Implant Urinary Incontinence Device Revenue (2020-2031) & (US$ Million)

Figure 51. U.K. Injectable Implant Urinary Incontinence Device Revenue (2020-2031) & (US$ Million)

Figure 52. Italy Injectable Implant Urinary Incontinence Device Revenue (2020-2031) & (US$ Million)

Figure 53. Russia Injectable Implant Urinary Incontinence Device Revenue (2020-2031) & (US$ Million)

Figure 54. Asia-Pacific Injectable Implant Urinary Incontinence Device Sales YoY (2020-2031) & (K Units)

Figure 55. Asia-Pacific Injectable Implant Urinary Incontinence Device Revenue YoY (2020-2031) & (US$ Million)

Figure 56. Asia-Pacific Top 8 Manufacturers Injectable Implant Urinary Incontinence Device Sales Revenue (US$ Million) in 2024

Figure 57. Asia-Pacific Injectable Implant Urinary Incontinence Device Sales Volume (K Units) by Type (2020- 2031)

Figure 58. Asia-Pacific Injectable Implant Urinary Incontinence Device Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 59. Asia-Pacific Injectable Implant Urinary Incontinence Device Sales Volume (K Units) by Application (2020-2031)

Figure 60. Asia-Pacific Injectable Implant Urinary Incontinence Device Sales Revenue (US$ Million) by Application (2020-2031)

Figure 61. Indonesia Injectable Implant Urinary Incontinence Device Revenue (2020-2031) & (US$ Million)

Figure 62. Japan Injectable Implant Urinary Incontinence Device Revenue (2020-2031) & (US$ Million)

Figure 63. South Korea Injectable Implant Urinary Incontinence Device Revenue (2020-2031) & (US$ Million)

Figure 64. China Taiwan Injectable Implant Urinary Incontinence Device Revenue (2020-2031) & (US$ Million)

Figure 65. India Injectable Implant Urinary Incontinence Device Revenue (2020-2031) & (US$ Million)

Figure 66. Central and South America Injectable Implant Urinary Incontinence Device Sales YoY (2020-2031) & (K Units)

Figure 67. Central and South America Injectable Implant Urinary Incontinence Device Revenue YoY (2020-2031) & (US$ Million)

Figure 68. Central and South America Top 5 Manufacturers Injectable Implant Urinary Incontinence Device Sales Revenue (US$ Million) in 2024

Figure 69. Central and South America Injectable Implant Urinary Incontinence Device Sales Volume (K Units) by Type (2021-2031)

Figure 70. Central and South America Injectable Implant Urinary Incontinence Device Sales Revenue (US$ Million) by Type (2020-2031)

Figure 71. Central and South America Injectable Implant Urinary Incontinence Device Sales Volume (K Units) by Application (2020-2031)

Figure 72. Central and South America Injectable Implant Urinary Incontinence Device Sales Revenue (US$ Million) by Application (2020-2031)

Figure 73. Brazil Injectable Implant Urinary Incontinence Device Revenue (2020-2025) & (US$ Million)

Figure 74. Argentina Injectable Implant Urinary Incontinence Device Revenue (2020-2025) & (US$ Million)

Figure 75. Middle East, and Africa Injectable Implant Urinary Incontinence Device Sales YoY (2020-2031) & (K Units)

Figure 76. Middle East and Africa Injectable Implant Urinary Incontinence Device Revenue YoY (2020-2031) & (US$ Million)

Figure 77. Middle East and Africa Top 5 Manufacturers Injectable Implant Urinary Incontinence Device Sales Revenue (US$ Million) in 2024

Figure 78. Middle East and Africa Injectable Implant Urinary Incontinence Device Sales Volume (K Units) by Type (2021-2031)

Figure 79. South America Injectable Implant Urinary Incontinence Device Sales Revenue (US$ Million) by Type (2020-2031)

Figure 80. Middle East and Africa Injectable Implant Urinary Incontinence Device Sales Volume (K Units) by Application (2020-2031)

Figure 81. Middle East and Africa Injectable Implant Urinary Incontinence Device Sales Revenue (US$ Million) by Application (2020-2031)

Figure 82. GCC Countries Injectable Implant Urinary Incontinence Device Revenue (2020-2025) & (US$ Million)

Figure 83. Turkey Injectable Implant Urinary Incontinence Device Revenue (2020-2025) & (US$ Million)

Figure 84. Egypt Injectable Implant Urinary Incontinence Device Revenue (2020-2025) & (US$ Million)

Figure 85. South Africa Injectable Implant Urinary Incontinence Device Revenue (2020-2025) & (US$ Million)

Figure 86. Injectable Implant Urinary Incontinence Device Industry Chain Mapping

Figure 87. Regional Injectable Implant Urinary Incontinence Device Manufacturing Base Distribution (%)

Figure 88. Global Injectable Implant Urinary Incontinence Device Production Market Share by Region (2020-2031)

Figure 89. Injectable Implant Urinary Incontinence Device Production Process

Figure 90. Regional Injectable Implant Urinary Incontinence Device Production Cost Structure

Figure 91. Channels of Distribution (Direct Vs Distribution)

Figure 92. Bottom-up and Top-down Approaches for This Report

Figure 93. Data Triangulation

Figure 94. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Injectable Implant Urinary Incontinence Device in 2031? zhanKai

The global market size of Injectable Implant Urinary Incontinence Device in 2031 was 185 Million USD.

What is the annual compound growth rate of the global Injectable Implant Urinary Incontinence Device market size from 2025 to 2031? shouQi

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Injectable Implant Urinary Incontinence Device market? shouQi

What was the global market size of Injectable Implant Urinary Incontinence Device in 2025? shouQi

Related Reports

Injectable Implant Urinary Incontinence Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 131 million in 2025 and is projected to reach US$ 194 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 121
USD 3950.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2026
The global Injectable Implant Urinary Incontinence Device market was valued at US$ 131 million in 2025 and is anticipated to reach US$ 194 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 104
USD 2900.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Injectable Implant Urinary Incontinence Device market size was US$ 124 million in 2024 and is forecast to a readjusted size of US$ 185 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 67
USD 4250.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2025
The global market for Injectable Implant Urinary Incontinence Device was valued at US$ 124 million in the year 2024 and is projected to reach a revised size of US$ 185 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-01-16
Pages: 67
USD 2900.00
(Single User License)
Injectable Implant Urinary Incontinence Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 124 million in 2024 and is forecast to a readjusted size of US$ 185 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 82
USD 3950.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Market Insights, Forecast to 2030
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published Date: 2024-04-12
Pages: 75
USD 4900.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2024
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published Date: 2024-01-17
Pages: 74
USD 2900.00
(Single User License)
Injectable Implant Urinary Incontinence Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published Date: 2024-01-10
Pages: 82
USD 3950.00
(Single User License)

Injectable Implant Urinary Incontinence Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 131 million in 2025 and is projected to reach US$ 194 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-06-16
Pages: 121
USD 3950.00 (Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2026
The global Injectable Implant Urinary Incontinence Device market was valued at US$ 131 million in 2025 and is anticipated to reach US$ 194 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-04-17
Pages: 104
USD 2900.00 (Single User License)
Global Injectable Implant Urinary Incontinence Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Injectable Implant Urinary Incontinence Device market size was US$ 124 million in 2024 and is forecast to a readjusted size of US$ 185 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 67
USD 4250.00 (Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2025
The global market for Injectable Implant Urinary Incontinence Device was valued at US$ 124 million in the year 2024 and is projected to reach a revised size of US$ 185 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-01-16
Pages: 67
USD 2900.00 (Single User License)
Injectable Implant Urinary Incontinence Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 124 million in 2024 and is forecast to a readjusted size of US$ 185 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 82
USD 3950.00 (Single User License)
Global Injectable Implant Urinary Incontinence Device Market Insights, Forecast to 2030
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published: 2024-04-12
Pages: 75
USD 4900.00 (Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2024
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published: 2024-01-17
Pages: 74
USD 2900.00 (Single User License)
Injectable Implant Urinary Incontinence Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published: 2024-01-10
Pages: 82
USD 3950.00 (Single User License)